To determine whether the decreased CD8+ T-cell response to lyticantigens is limited to EBV infection, we also measured the T-cell response to apool of 18 HLA-class-I-restricted peptide epitopes of CMV, as a controlherpesvirus, in the subjects who were CMV-seropositive. This evidence concerns the gene CD8A and Epstein-Barr virus infection.